M&A Roll-Up Playbook: The IRR Framework That Replaced Budgets at Zayo | Dan Caruso (Part 2)
M&A Science9 Huhti

M&A Roll-Up Playbook: The IRR Framework That Replaced Budgets at Zayo | Dan Caruso (Part 2)

Dan Caruso, Managing Director, Caruso Ventures; Founding CEO of Zayo Group

This is Part 2 of our conversation with Dan Caruso, founder and former CEO of Zayo Group. Be sure to start with Part 1. It covers the Zayo thesis, deal sourcing, structure, and the negotiation playbook, whereas this episode picks up at the execution.

Part 2 is about the equity value-creation framework Dan built at Zayo, applying the same IRR math PE firms use for their portfolio companies to daily operating decisions. It replaced budgets and tied every compensation decision to a single equation. It ends with the exit and how Dan put together a competing bid after a buyer consortium locked up the debt market.

What You'll Learn

  • How Zayo's integration process matured across 45 deals + where it broke post- IPO
  • The equity value creation model: the IRR metric that replaced budgets and tied compensation to a single equation
  • Negotiation tactics: countering lower, manufacturing urgency, and splitting the CEO from their investor at the table
  • Culture during integration: one culture, take it or leave it
  • IRR compression as a sell signal and how Dan acted on it before most saw it coming
  • The sell process: engineering a competing bid after buyers locked up the debt market
  • The ICG deal: $8.7M in, $250M out, 18 months

Want to apply Dan's framework to your own business? The Intelligence Hub has the Equity Value Creation Operating Model, a step-by-step guide to replacing budget-based management with IRR as your operating compass. Access here.

____________________

This episode is sponsored by DealRoom

M&A Science is heading to ACG DealMax in Las Vegas, April 27–29 and we'd love to see you there. Stop by the booth for a book signing, swag, and a look at what the M&A Science and DealRoom teams have been building.
Learn more and save the date: https://hubs.ly/Q043VnNH0

____________________

Episode Chapters

[00:02:28] Public company vs. private: what changed about deal execution.

[00:03:40] Negotiation tactics: countering lower, manufacturing urgency, the CEO-investor wedge.

[00:08:15] Integration maturity: how execution evolved across 45+ deals.

[00:18:43] Culture: join us or don't.

[00:20:35] Going public: super voting shares, activist investors, and the PR game Dan skipped.

[00:24:40] Post-IPO talent drain and what Dan would restructure in management equity.

[00:29:26] When to sell: reading value compression.

[00:33:03] The sell process: competing bid against a cornered debt market.

[00:39:18] The equity value creation model: replacing budgets with IRR.

[00:43:29] IRR as a real-time operating metric.

[00:49:50] Cruso Ventures, quantum, space, and Boulder Roots Music Fest.

[01:01:06] The ICG deal: $8.7M in, $250M out

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(417)

The Nordic Compounder Playbook: How Lagercrantz Bought 90 Companies and Never Sold One

The Nordic Compounder Playbook: How Lagercrantz Bought 90 Companies and Never Sold One

Jörgen Wigh, CEO of Lagercrantz Group Jörgen Wigh has been CEO of Lagercrantz Group (STO: LAGR-B) for over 20 years. In that time he completed 90+ acquisitions, built a portfolio of 85 niche B2B compa...

28 Touko 42min

M&A Integration Technology: What Actually Works

M&A Integration Technology: What Actually Works

Jim Buckley, VP M&A Integration at Coursera | Todd Manley, VP of Corp Dev Integration at Intel | Carey Pugh is Sr. Director, M&A Corporate Integration at Ansys | Mahesh Ganesan, Sr. Director, M&A Inte...

21 Touko 50min

Partner Before You Buy: The Pre-Acquisition Strategy Corp Dev Teams Skip

Partner Before You Buy: The Pre-Acquisition Strategy Corp Dev Teams Skip

Tomer Stavitsky is SVP and Chief Corporate Development Officer at Omnicell (NASDAQ: OMCL) Corp dev teams treat M&A and partnerships as separate tracks, but Tomer Stavitsky looks at them holistically. ...

14 Touko 52min

How M&A Turns a Chemical Company Into a Tech Business

How M&A Turns a Chemical Company Into a Tech Business

Chandradev Mehta, SVP Strategy and Business Development at Hexion Inc. Chandradev Mehta, SVP Strategy and Business Development at Hexion Inc., breaks down how a commodity chemical company uses M&A to ...

7 Touko 53min

CPG Exit Strategy: How to Build a Consumer Brand Strategics Will Acquire | Keith Levy Part 2

CPG Exit Strategy: How to Build a Consumer Brand Strategics Will Acquire | Keith Levy Part 2

Keith Levy, Operating Partner at Sonoma Brands Capital Most consumer brand founders think about exit as an event. Keith Levy thinks about it as a design requirement. In the second of two episodes, Kei...

30 Huhti 57min

CPG Due Diligence: The Operator Framework Behind a $1B Exit | Keith Levy Part 1

CPG Due Diligence: The Operator Framework Behind a $1B Exit | Keith Levy Part 1

Keith Levy, Operating Partner at Sonoma Brands Capital Keith Levy backed an exit of just under $1B  and a $400M exit using the same five-pillar framework, and he starts with the founder every time. Fi...

23 Huhti 53min

400 Acquisitions and a Failed Process: What Happens When You Don't Integrate

400 Acquisitions and a Failed Process: What Happens When You Don't Integrate

Matt James, EVP, CFO & Chief Acquisition Officer at Oakbridge Insurance Roll-up platforms that skipped real integration are getting exposed when they go to market. Buyers want proof of organic growth,...

16 Huhti 58min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
mimmit-sijoittaa
rss-rahapodi
rss-oivalluksia-rahasta-elamasta
hyva-paha-johtaminen
rss-rahamania
rss-set-for-life-sijoita-ja-vaurastu
ostan-asuntoja-podcast
rss-lahtijat
rss-karon-grilli
rss-sisalto-kuntoon
inderespodi
rss-sami-miettinen-neuvottelija
asuntoasiaa-paivakirjat
rss-paasipodi
rss-myynnilla-on-asiaa-kert-kenner
pomojen-suusta
rss-paras-paikka-ihmiselle
rss-seuraava-potilas